These observations suggest that FAM84B has cancer-promoting properties contributing to poor outcome after recurrence, and that MYC is not the only oncogene located in this frequently amplified genomic region, supporting a role for the nearby FAM84B gene as a novel potential driver oncogene in human breast cancer. This evidence concerns the gene LRATD2 and breast carcinoma.